Serodus ASA is a Scandinavian drug development company, focusing on new therapeutic products for the treatment of Diabetic Kidney Disease.
Serodus strives to increase shareholders value through advancing its portfolio to value-creating clinical milestones. With the current drug candidates supported by exceptional competencies to develop them, Serodus is uniquely positioned for success. Below are the key focus elements:
Strategic focus on Diabetic Kidney Disease
Serodus has taken a strategic decision to focus on Diabetic Kidney Disease with significant unmet needs. The market potentials for the drug candidates are large and growing. The growth is driven by increased wealth, change of lifestyle and the aging population.
Serodus maintains a small, dedicated management team without investing in own laboratories. With close partnerships with universities and contract research organization Serodus involves the best competencies for the tasks. It also gives the company a predictable progress in project, minimizing overhead costs.
Strong management team with proven record
Serodus management has a strong competence and proven track record in drug development. As a result, Serodus is in a unique position to succeed with the clinical programs.